11. Income Taxes
Income taxes have been recorded on the following losses before income taxes:
|
(in thousands) |
|
|
As of December 31, |
|
||||||||||
|
|
|
2015 |
|
2016 |
|
2017 |
|
|||||||
|
Domestic operations |
|
$ |
(45,361) |
|
$ |
(52,545) |
|
$ |
(52,568) |
|
||||
|
Foreign operations |
|
|
(13,290) |
|
|
(39,148) |
|
|
(16,791) |
|
||||
|
Loss before provision for income taxes |
|
$ |
(58,651) |
|
$ |
(91,693) |
|
$ |
(69,359) |
|
||||
The benefit for income taxes consists of the following for 2015, 2016 and 2017:
|
|
|
As of |
|
|||||||
|
(in thousands) |
|
December 31, |
|
|||||||
|
|
|
2015 |
|
2016 |
|
2017 |
|
|||
|
Current: |
|
|
|
|
|
|
|
|
|
|
|
U.S. federal |
|
$ |
— |
|
$ |
— |
|
$ |
— |
|
|
State and local |
|
|
— |
|
|
— |
|
|
— |
|
|
Foreign |
|
|
— |
|
|
— |
|
|
— |
|
|
Total current taxes |
|
|
— |
|
|
— |
|
|
— |
|
|
Deferred: |
|
|
|
|
|
|
|
|
|
|
|
U.S. federal |
|
$ |
— |
|
$ |
— |
|
$ |
— |
|
|
State and local |
|
|
(700) |
|
|
(1,061) |
|
|
— |
|
|
Foreign |
|
|
(18) |
|
|
— |
|
|
— |
|
|
Total deferred taxes |
|
|
(718) |
|
|
(1,061) |
|
|
— |
|
|
Total income tax benefit |
|
$ |
(718) |
|
$ |
(1,061) |
|
$ |
— |
|
For the years ended December 31, 2015, 2016 and 2017, the Company had no interest or penalties accrued related to unrecognized tax benefits. Any interest and penalties relating to unrecognized tax benefits will be recorded as a component of income tax expense. The following table indicates the changes to the Company’s unrecognized tax benefits:
|
(in thousands) |
|
For the Year Ended |
|
|||||||
|
|
|
December 31, |
|
|||||||
|
|
|
2015 |
|
2016 |
|
2017 |
|
|||
|
Beginning balance |
|
$ |
59 |
|
$ |
73 |
|
$ |
73 |
|
|
Increase related to prior tax years |
|
|
14 |
|
|
— |
|
|
— |
|
|
Increase related to current year |
|
|
— |
|
|
— |
|
|
— |
|
|
Ending balance |
|
$ |
73 |
|
$ |
73 |
|
$ |
73 |
|
Of the Company’s unrecognized tax benefits, none would affect the Company’s effective tax rate in the period recognized due to the offsetting impact of the valuation allowance recorded against the Company’s net operating losses. The Company does not expect its unrecognized tax benefit liability to change significantly over the next 12 months.
The principal components of the Company’s deferred tax assets and liabilities were as follows:
|
(in thousands) |
|
|
As of December 31, |
|
|||
|
|
|
2016 |
|
2017 |
|
||
|
Deferred tax assets: |
|
|
|
|
|
|
|
|
Inventory |
|
$ |
714 |
|
$ |
96 |
|
|
Accrued expenses |
|
|
1,049 |
|
|
725 |
|
|
Deferred revenue |
|
|
1,484 |
|
|
1,843 |
|
|
Stock-based compensation expense |
|
|
1,183 |
|
|
1,072 |
|
|
Intangible assets |
|
|
1,307 |
|
|
969 |
|
|
Other |
|
|
366 |
|
|
341 |
|
|
Other debt |
|
|
1,288 |
|
|
1,149 |
|
|
Net operating losses |
|
|
51,932 |
|
|
56,943 |
|
|
Deferred tax assets |
|
|
59,323 |
|
|
63,138 |
|
|
Deferred tax liabilities: |
|
|
|
|
|
|
|
|
Fixed assets |
|
$ |
(651) |
|
$ |
(747) |
|
|
Convertible notes |
|
|
(5,039) |
|
|
(1,445) |
|
|
Deferred tax liabilities |
|
|
(5,690) |
|
|
(2,192) |
|
|
Net deferred tax assets |
|
|
53,633 |
|
|
60,946 |
|
|
Less: valuation allowance |
|
|
(53,656) |
|
|
(60,966) |
|
|
Net deferred tax liabilities after valuation allowance |
|
$ |
(23) |
|
$ |
(20) |
|
As of December 31, 2017, the Company had foreign net operating loss (“NOL”) carry forwards of $97.1 million from its operations in Denmark, which are available to reduce future foreign taxable income. The NOL carry forwards are not subject to future expiration and may be carried forward indefinitely. However, if there is a more than 50% change of stockholders by value or vote at the end of the tax year as compared to the beginning of the tax year, these existing foreign NOLs may not be available to offset certain types of future foreign income (generally, “net financial income”, which includes interest income net of interest expense, dividends, and capital gains and losses). The Company files income tax returns in the U.K., because Egalet Limited (“Egalet UK”) was incorporated in that jurisdiction; however, Egalet UK has no business operations in the U.K. and the Company has no plans to commence operations in that jurisdiction in the foreseeable future. As such, the Company has determined that it will not record U.K. NOL’s as a component of their deferred tax inventory, since there is currently no expectation that the NOLs will ever be realized. As of December 31, 2017, the Company had U.S. federal and state NOL’s of $137.9 million and $91.8 million, respectively. These domestic NOL carry forwards may become subject to an annual limitation in the event of certain cumulative changes in the ownership interest of significant stockholders over a three‑ year period in excess of 50%. This could limit the amount of NOLs that the Company can utilize annually to offset future domestic taxable income or tax liabilities, if any. The amount of the annual limitation, if any, will be determined based on the value of the Company immediately prior to the ownership change. Subsequent ownership changes may further affect the limitation in future years. These federal and state NOL’s will begin to expire in 2033 and through 2036.
ASC 740 – Tax Provisions requires a valuation allowance to reduce the deferred tax assets reported if, based on the weight of available evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized. After consideration of all the evidence, both positive and negative, the Company has recorded a full valuation allowance against its net deferred tax assets at December 31, 2016 and 2017, respectively, because the Company has determined that is it more likely than not that these assets will not be fully realized. The Company experienced a net change in valuation allowance of $27.9 million and $7.3 million, which includes the impact of the Tax Reform for the years ended December 31, 2016 and 2017, respectively.
At December 31, 2017, no provision has been made for U.S. federal and state income taxes of foreign earnings due to the history of foreign losses. However, the Company expects that the future earnings, if any, of its foreign subsidiaries will be reinvested indefinitely. Upon becoming profitable, if ever, distribution of these earnings, in the form of dividends or otherwise, may result in the Company falling subject to U.S. income taxes and foreign withholding taxes. The determination of the amount of unrecognized deferred U.S. income tax expense and foreign withholding tax liabilities on these future earnings, if any, is not practicable because of the complexities with the hypothetical calculations.
The Company files income tax returns in Denmark, the U.K., the United States, and in various U.S. states. The foreign tax returns are subject to tax examinations for the tax years ended July 31, 2012 through December 31, 2017. The domestic tax returns are subject to tax examinations for the tax years ended December 31, 2014 through December 31, 2017. However, to the extent the Company utilizes in the future any tax attribute NOL carry forwards from a tax period that may otherwise be closed to examination, the Internal Revenue Service, state tax authorities, or other governing parties may still adjust the NOL upon their examination of the future period in which the attribute was utilized.
A reconciliation of income tax expense (benefit) at the statutory federal income tax rate and income taxes as reflected in the financial statements is as follows:
|
|
|
For the Year |
|
||
|
|
|
Ended |
|
||
|
(in thousands) |
|
December 31, |
|
||
|
|
|
2016 |
|
2017 |
|
|
Federal income tax at the statutory rate |
|
34.0 |
% |
34.0 |
% |
|
Permanent tax items |
|
(0.5) |
|
(0.3) |
|
|
State income tax, net of federal benefit |
|
2.2 |
|
2.6 |
|
|
Change in foreign tax rate |
|
(5.4) |
|
(3.1) |
|
|
Equity compensation shortfall |
|
|
|
(0.7) |
|
|
Tax reform rate change |
|
|
|
(25.8) |
|
|
Change in valuation allowance |
|
(29.2) |
|
(6.7) |
|
|
Effective income tax rate |
|
1.1 |
% |
— |
% |
|
The Cuts and Jobs Act (the “Tax Act”) was enacted on December 22, 2017 and was the driver of the rate change item above. |
|||||